Trial Profile
Prevention of portal vein thrombosis with anticoagulant therapy in patients with hepatic cirrhosis: a randomised controlled trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2017
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- 30 Aug 2012 Status changed from recruiting to completed as reported by ISRCTN.
- 23 Feb 2012 Planned end date changed from 16 Oct 2008 to 30 Aug 2012 as reported by ISRCTN.
- 30 Aug 2011 New trial record